NO20025595D0 - Anvendelse av Lactobacillus casei i immunstimulerende peptider - Google Patents
Anvendelse av Lactobacillus casei i immunstimulerende peptiderInfo
- Publication number
- NO20025595D0 NO20025595D0 NO20025595A NO20025595A NO20025595D0 NO 20025595 D0 NO20025595 D0 NO 20025595D0 NO 20025595 A NO20025595 A NO 20025595A NO 20025595 A NO20025595 A NO 20025595A NO 20025595 D0 NO20025595 D0 NO 20025595D0
- Authority
- NO
- Norway
- Prior art keywords
- lactobacillus casei
- immune stimulating
- stimulating peptides
- peptides
- immune
- Prior art date
Links
- 244000199866 Lactobacillus casei Species 0.000 title 1
- 235000013958 Lactobacillus casei Nutrition 0.000 title 1
- 229940017800 lactobacillus casei Drugs 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0006679A FR2809312B1 (fr) | 2000-05-25 | 2000-05-25 | Utilisation de l. casei dans des compositions immunostimulantes |
PCT/FR2001/001310 WO2001089541A1 (fr) | 2000-05-25 | 2001-04-27 | Utilisation de lactobacillus casei dans des peptides immunostimulantes |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20025595D0 true NO20025595D0 (no) | 2002-11-21 |
NO20025595L NO20025595L (no) | 2003-01-22 |
NO332369B1 NO332369B1 (no) | 2012-09-03 |
Family
ID=8850597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20025595A NO332369B1 (no) | 2000-05-25 | 2002-11-21 | Anvendelse av Lactobacillus casei stammen CNCM I-1518 for fremstilling av et preparat for a forsterke en spesifikk systemisk immunrespons mot et influensa-virus. |
Country Status (28)
Country | Link |
---|---|
US (1) | US7604809B2 (no) |
EP (1) | EP1283714B1 (no) |
JP (1) | JP2003534284A (no) |
CN (1) | CN1194707C (no) |
AR (1) | AR028626A1 (no) |
AT (1) | ATE332143T1 (no) |
AU (2) | AU5643501A (no) |
BG (1) | BG65884B1 (no) |
BR (1) | BR0111135A (no) |
CA (1) | CA2410350C (no) |
CZ (1) | CZ303600B6 (no) |
DE (1) | DE60121327T2 (no) |
DK (1) | DK1283714T3 (no) |
EA (1) | EA005081B1 (no) |
ES (1) | ES2267763T3 (no) |
FR (1) | FR2809312B1 (no) |
HK (1) | HK1055898A1 (no) |
HR (1) | HRP20020935A2 (no) |
HU (1) | HUP0302041A3 (no) |
IL (1) | IL152980A0 (no) |
MA (1) | MA25760A1 (no) |
MX (1) | MXPA02011636A (no) |
NO (1) | NO332369B1 (no) |
PL (1) | PL201801B1 (no) |
PT (1) | PT1283714E (no) |
SK (1) | SK18272002A3 (no) |
WO (1) | WO2001089541A1 (no) |
ZA (1) | ZA200209087B (no) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6800744B1 (en) * | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
GB0009294D0 (en) | 2000-04-15 | 2000-05-31 | Sec Dep For The Home Departmen | Improvements in and relating to analysis of DNA samples |
US9610347B2 (en) * | 2001-04-30 | 2017-04-04 | Cortcontrol | Vaccination response for immunodeficiency or high cortisol |
CN1317385C (zh) * | 2003-05-30 | 2007-05-23 | 上海光明乳业股份有限公司 | 干酪乳杆菌Bd-II菌株及其在降低血脂方面的应用 |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
ATE361101T1 (de) * | 2004-08-24 | 2007-05-15 | Nutricia Nv | Nahrungszusammensetzung die unverdauliche oligosaccharide enthält |
ZA200705844B (en) * | 2004-12-15 | 2008-09-25 | Van Der Westhuzen Corne Floris | Detoxifying and immunity-booster composition |
EP1683425A1 (en) * | 2005-01-21 | 2006-07-26 | Compagnie Gervais Danone | Use of a fermented milk containing L. Casei for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction |
ES2264368B1 (es) * | 2005-02-11 | 2007-12-01 | Francisco Exposito Mesa | Complemento alimenticio o dietetico compuesto por productos procedentes del lisado de microorganismos. |
BRPI0611492B1 (pt) | 2005-05-31 | 2021-10-13 | Mars, Incorporated | Bifidobactéria probiótica felina |
WO2006130187A1 (en) | 2005-05-31 | 2006-12-07 | The Iams Company | Feline probiotic lactobacilli |
CA2662226C (en) | 2006-09-10 | 2020-08-04 | Glycotope Gmbh | Fully human high yield production system for improved antibodies and proteins |
FR2912657B1 (fr) * | 2007-02-16 | 2009-04-17 | Gervais Danone Sa | Utilisation de lactobacillus casei pour renforcer la protection induite par la vaccination anti-grippale. |
WO2009021585A1 (en) * | 2007-08-13 | 2009-02-19 | Dsm Ip Assets B.V. | Probiotic bacteria for rducing the occurence of symptoms of winter infections |
WO2009067000A1 (en) * | 2007-11-20 | 2009-05-28 | N.V. Nutricia | Composition with synbiotics |
EP2119365B1 (de) | 2008-05-13 | 2017-08-16 | Glycotope GmbH | Fermentationsprozess |
CA2722738C (en) * | 2008-05-13 | 2017-04-25 | Glycotope Gmbh | Fermentation process |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
EP2153837A1 (en) | 2008-08-14 | 2010-02-17 | Compagnie Gervais Danone | Compositions comprising Lactobacillus casei for improving resistance to common infectious diseases |
FR2937252B1 (fr) * | 2008-10-17 | 2011-05-20 | Pf Medicament | Association d'un extrait de sureau et d'une souche de l. paracasei. |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
BR112012016894A2 (pt) * | 2010-01-08 | 2015-09-15 | Gervais Danone Sa | lactobacilos com ação antioxidante. |
EA031179B1 (ru) * | 2010-03-12 | 2018-11-30 | Компани Жервэ Данон | Молочнокислые бактерии, применяемые при чревной болезни |
CN105288616B (zh) * | 2010-10-15 | 2018-10-19 | 科.汉森有限公司 | 免疫佐剂 |
EP2455092A1 (en) | 2010-11-11 | 2012-05-23 | Nestec S.A. | Non-replicating probiotic micro-organisms protect against upper respiratory tract infections |
US9700610B2 (en) | 2011-08-22 | 2017-07-11 | Glycotope Gmbh | Microorganisms carrying a tumor antigen |
WO2014038929A1 (en) | 2012-09-07 | 2014-03-13 | N.V. Nutricia | Probiotics for producing antiviral factors |
CA3100608A1 (en) | 2018-05-18 | 2019-11-21 | Daiichi Sankyo Co., Ltd. | Anti-muc1 antibody-drug conjugate |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05236872A (ja) * | 1992-02-27 | 1993-09-17 | Takanashi Nyugyo Kk | 乳酸菌含有食品 |
JP4112021B2 (ja) * | 1994-02-16 | 2008-07-02 | 明治乳業株式会社 | 乳酸菌を用いた免疫賦活剤 |
WO1996020607A1 (fr) * | 1995-01-02 | 1996-07-11 | Compagnie Gervais Danone | Ferment lactique, et son utilisation pour la preparation de produits anti-diarrheiques |
CN1150314C (zh) * | 1997-08-21 | 2004-05-19 | 纽西兰乳品局 | 增强免疫的乳酸菌 |
US6699517B2 (en) * | 1997-11-28 | 2004-03-02 | Compagnie Gervais Danone | Method for preparing food products by fermenting soy milk with streptococcus thermophilus |
IT1298918B1 (it) * | 1998-02-20 | 2000-02-07 | Mendes Srl | Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche |
KR100324441B1 (ko) * | 1999-02-08 | 2002-02-27 | 이은선 | 위염, 위궤양, 십이지장궤양 예방을 위한 식품 |
-
2000
- 2000-05-25 FR FR0006679A patent/FR2809312B1/fr not_active Expired - Fee Related
-
2001
- 2001-04-27 HU HU0302041A patent/HUP0302041A3/hu unknown
- 2001-04-27 SK SK1827-2002A patent/SK18272002A3/sk not_active Application Discontinuation
- 2001-04-27 AU AU5643501A patent/AU5643501A/xx active Pending
- 2001-04-27 MX MXPA02011636A patent/MXPA02011636A/es active IP Right Grant
- 2001-04-27 JP JP2001585785A patent/JP2003534284A/ja active Pending
- 2001-04-27 BR BR0111135-3A patent/BR0111135A/pt not_active IP Right Cessation
- 2001-04-27 PT PT01929743T patent/PT1283714E/pt unknown
- 2001-04-27 EP EP01929743A patent/EP1283714B1/fr not_active Expired - Lifetime
- 2001-04-27 AT AT01929743T patent/ATE332143T1/de active
- 2001-04-27 DK DK01929743T patent/DK1283714T3/da active
- 2001-04-27 CA CA2410350A patent/CA2410350C/fr not_active Expired - Lifetime
- 2001-04-27 CN CNB018100511A patent/CN1194707C/zh not_active Expired - Fee Related
- 2001-04-27 US US10/276,315 patent/US7604809B2/en not_active Expired - Fee Related
- 2001-04-27 WO PCT/FR2001/001310 patent/WO2001089541A1/fr active IP Right Grant
- 2001-04-27 AU AU2001256435A patent/AU2001256435B2/en not_active Ceased
- 2001-04-27 ES ES01929743T patent/ES2267763T3/es not_active Expired - Lifetime
- 2001-04-27 IL IL15298001A patent/IL152980A0/xx unknown
- 2001-04-27 CZ CZ20024189A patent/CZ303600B6/cs unknown
- 2001-04-27 PL PL358408A patent/PL201801B1/pl unknown
- 2001-04-27 EA EA200201248A patent/EA005081B1/ru not_active IP Right Cessation
- 2001-04-27 DE DE60121327T patent/DE60121327T2/de not_active Expired - Lifetime
- 2001-05-24 AR ARP010102498A patent/AR028626A1/es unknown
-
2002
- 2002-11-08 ZA ZA200209087A patent/ZA200209087B/xx unknown
- 2002-11-20 BG BG107299A patent/BG65884B1/bg unknown
- 2002-11-21 NO NO20025595A patent/NO332369B1/no not_active IP Right Cessation
- 2002-11-25 HR HR20020935A patent/HRP20020935A2/hr not_active Application Discontinuation
- 2002-12-20 MA MA26968A patent/MA25760A1/fr unknown
-
2003
- 2003-11-12 HK HK03108188A patent/HK1055898A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20025595D0 (no) | Anvendelse av Lactobacillus casei i immunstimulerende peptider | |
HUP0301003A3 (en) | Casein derived peptides and uses thereof in therapy | |
AU7616001A (en) | Probiotic recolonisation therapy | |
AU1166502A (en) | Human ect2 and methods of use | |
IS2620B (is) | Mennskgerð mótefni sem greina beta-amýlóíðpeptíð | |
AU2001256435A1 (en) | Use of lactobacillus casei in immunostimulatory compositions | |
NO20025657D0 (no) | Anvendelse av Baculovirus-vektorer i genterapi | |
EP1379535A4 (en) | FOR OBTAINING AN IMPROVED IMMUNE RESPONSE, EXPRESSION VECTORS, AND METHOD FOR THEIR USE | |
AU6723401A (en) | Antimicrobial peptides and methods of use thereof | |
AU2002243363A8 (en) | Use of aziridino-compounds in the treatment of immune dysfunctions | |
NO20031525L (no) | Kjemokinmutanter i behandlingen av multippel sklerose | |
IL190490A0 (en) | Enantiomerically pure cyclic ketones and their use in the synthesis of amino acids | |
HUP0500995A2 (en) | Casein derived peptides and uses thereof in therapy | |
IL150679A0 (en) | Use of mia in immunotherapy | |
EP1197557A4 (en) | GENE ENCODING CYCLIC LIPOPEPTID ACYLASE AND THEIR EXPRESSION | |
EP1317271A4 (en) | THERAPEUTIC AND COSMETIC USES OF HEPARANASES | |
GB9912085D0 (en) | Use of amino acids in hair treatment | |
EP1618124A4 (en) | PROPHYLACTIC AND THERAPEUTIC ADVANTAGES OF AN IMMUNE STIMULATION PEPTIDE CLASS | |
NO20030762D0 (no) | Forbedret spesifisitet i behandling av sykdommer | |
GB0017028D0 (en) | Peptides and their therapeutic use | |
DE60110503D1 (de) | Immunostimulierende Zusammensetzung enthaltend Peptid und Hyaluronsäure | |
IL151351A0 (en) | Casein derived peptides and uses thereof in therapy | |
TW461318U (en) | Improved structure of massaging chair | |
AU2002302618A1 (en) | 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases | |
PL336946A1 (en) | Rehabilitation mattress made of wood and sponge |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |